Please login to the form below

rheumatoid arthritis

This page shows the latest rheumatoid arthritis news and features for those working in and with pharma, biotech and healthcare.

GSK sells eczema and psoriasis drug to Dermavant for £250m

The cut included IL-6 inhibitor sirukumab for rheumatoid arthritis, which left tapinarof as the lead candidate in its immuno-inflammation programme.

Latest news

Another R&D flop for Incyte, but Jakafi keeps delivering

Nevertheless, it’s another bit of bad news for Incyte after the epacadostat failure, what looks likely to be reduced royalties from Eli Lilly for rheumatoid arthritis JAK inhibitor Olumiant (baricitinib)
AbbVie builds case for arthritis blockbuster-in-waiting upadacitinib

AbbVie’s run of positive results for upadacitinib in rheumatoid arthritis continues with new data at EULAR on patients’experience with the drug. ... AbbVie says patient-reported outcome data are “an important component of understanding how
Roche’s MabThera ends drug drought for serious skin disease

Rituximab already has a long list of approved indications – including autoimmune disease rheumatoid arthritis, granulomatosis with polyangiitis (GPA), and microscopic polyangiitis (MPA) – and despite being on the market for more than
Pfizer’s Xeljanz picks up a third indication in IBD

placebo. Xeljanz is already doing well in the arthritis disease area - after picking up US approvals in rheumatoid arthritis and psoriatic arthritis - where the drug is the first and only JAK
Pfizer’s Xeljanz picks up a third indication in the US

placebo. Xeljanz is already doing well in the arthritis disease area - after picking up US approvals in rheumatoid arthritis and psoriatic arthritis - where the drug is the first and only JAK

More from news
Approximately 59 fully matching, plus 423 partially matching documents found.

Latest Intelligence

Finding the patient voice

rheumatoid arthritis, oncology, psychiatry, cardiovascular diseases, rare diseases etc.
The tipping point

In chronic diseases such as rheumatoid arthritis and inflammatory bowel disease, there are significantly greater savings from switching patients compared with initiating biosimilars in naïve patients alone.
Mobile health and patient outcomes

In a recent study in rheumatoid arthritis, patients saw pain as the key measure of treatment success, confounding the objective ‘clinical evidence’of improvement.
Grünenthal's relentless pursuit of relief

Pain has nervous and inflammatory components and we are interested in everything around the inflammatory process but also the central nervous system aspect of pain and adjunctive diseases such as rheumatoid ... arthritis and Parkinson’s.
Deal Watch December 2016

510. Nuevolution (Denmark). Almirall (Spain). Research collaboration. RORγt inhibitors for inflammatory skin diseases and psoriatic arthritis. ... The Scandinavian company, Nuevolution, uses its drug discovery platform Chemetics to discover novel small

More from intelligence
Approximately 0 fully matching, plus 32 partially matching documents found.

Latest appointments

Lilly and NRAS launch arthritis awareness film campaign

Eli Lilly and the National Rheumatoid Arthritis Society (NRAS) have launched a film-led disease awareness campaign in the UK for rheumatoid arthritis. ... The film - called Behind The Smile - coincides with rheumatoid arthritis (RA) awareness week and
Portland Health appoints Jamie Hewitt as an account director

Portland Health appoints Jamie Hewitt as an account director. He was previously the National Rheumatoid Arthritis Society's government affairs head. ... He joins the firm from the National Rheumatoid Arthritis Society, where he was its head of government
Liberation Unlimited promotes Vicky Smith

oncology, rheumatoid arthritis and eye health.
Galapagos appoints Bart Filius as chief financial officer

His vast experience in big pharma and his sharp strategic view will help us bring Galapagos to the next level, as we prepare to have our rheumatoid arthritis molecule GLPG0634 enter
TiGenix appoints Dr Marie Paule Richard

In her new role Richard will be responsible for the development of several products in Europe and the US, including rheumatoid arthritis and severe sepsis candidate Cx611 and Cx601, which is

More from appointments
Approximately 2 fully matching, plus 6 partially matching documents found.

Latest from PMHub

Infographic: RA market snapshot

Infographic: RA market snapshot. An overview of the RA biologic patient. Our RA market snapshot will provide you with an introduction to the treatment pathways followed by RA patients treated with biologic agents. Our analyses are based on 139, 984
Living with RA Report

Living with RA Report. Living with Rheumatoid Arthritis 2016 is a new syndicated report which offers low-cost, high-value quantitative insight into patient attitudes and behaviour.
Research Partnership publishes 2016 Living with RA reports

Research Partnership publishes 2016 Living with RA reports. Research Partnership has published new Living with rheumatoid arthritis (RA) EU and US market reports for 2016. ... Living with RA is a quantitative study conducted online amongst 500 patients
Infographic: RA Perceptions

adalimumab) to continue to lead the market and be used to treat over a third of Rheumatoid Arthritis (RA) patients in three years’ time.
THE OTHER SIDE OF … RHEUMATOID ARTHRITIS

THE OTHER SIDE OF … RHEUMATOID ARTHRITIS. “ I harassed my GP enough to get it caught early”. ... Meet Georgie. At age 26, Georgie was diagnosed with rheumatoid arthritis, an autoimmune inflammatory condition that affects up to 1% of the population

More from PMHub
Approximately 9 fully matching, plus 7 partially matching documents found.

Featured jobs

Strategic Planner, Healthcare Advertising: £47, 000 – £53, 000

Senior Project Manager - Medical Writing: Great salary and bebefits

Account Director, Medical Communications: C£50 – 65, 000 benefits and bonus

Home based, Editorial Team Leader, Medical Communications: Excellent package

Senior Account Manager: Competitive salary commensurate with experience

Delivery Manager/ Head of Delivery – Executive Search: Neg

Editorial Director – Medical Education (MedComms): Neg

Client Services Director - Med Comms: Great salary and bebefits

Home based, Chief Medical Writer, Medical Communications: Excellent package

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Account Manager: £40, 000 - £45, 000 benefits

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Scientific Communications Director - Oncology – In House Pharma ...: Neg

Client Services Director – Healthcare Advertising - London: Neg

Home based, Principal Medical Writer, Medical Communications: Excellent package

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Healthcare PR Director: £100, 000 – £120, 000 benefits

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Business Unit Head, Medical Communications, London: Excellent package

Home based, Senior Medical Writer, Medical Communications: Excellent package

Subscribe to our email news alerts

PMHub

Add my company

Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...